Lars Fruergaard

Lars Fruergaard is the former CEO of Novo Nordisk, a leading global healthcare company specializing in diabetes care and other chronic conditions. His tenure was marked by significant advancements in diabetes management and innovative treatments, contributing to Novo Nordisk's reputation as a key player in the pharmaceutical industry. Fruergaard was in the news following his dismissal in May 2023, which highlighted the substantial influence of the Novo Nordisk Foundation and its chairman, Lars Rebien Sørensen, over the company's leadership.